Delivery Order HHSN268201600034I-HHSN26800002

Award Date 9/26/16
Potential Completion Date 4/30/20
Potential Value $2.3M
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02142, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
6
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award issued by the National Heart, Lung and Blood Institute (NHLBI) to the Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard, is for $3,633,985.00 to support the Trans-Omics for Precision Medicine (TOPMed) initiative. The work will cover Task Areas 2, 3, and 4 of the TOPMed Centralized Omics Resource (CORE) contract, and includes genomics data generation, analysis, and management services to be performed at the Broad's facilities in Cambridge, MA....
This federal contract award, valued at $36,406,715.12, was issued by the National Heart Lung and Blood Institute (NHLBI) to The Broad Institute, Inc. (doing business as Broad Institute of MIT and Harvard), a non-profit biomedical and genomic research organization. The award is for the fifth year of the Centralized Omics Resource (CORE) contract, which is a delivery order under the Centralized Omic REsource for TOPMed (CORE) master IDIQ contract. The contract does not have a set-aside...
The National Institutes of Health National Heart, Lung and Blood Institute awarded a $22.4 million firm fixed price delivery order to The Broad Institute, Inc. under the Centralized Omic REsource for TOPMed (CORE) multiple award IDIQ. The Broad Institute will provide sequencing services to support the Trans-Omics for Precision Medicine program. As a non-profit research organization partnering with universities and medical centers, The Broad Institute leverages over $500 million in federal...
This is a $8,473,939.55 firm fixed-price delivery order awarded to The Broad Institute, Inc. by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The work is performed in support of the Centralized Omics Resource (CORE) program, which provides genomics data generation, analysis, and management services for the Trans-Omics for Precision Medicine (TOPMed) initiative. The Broad Institute is the prime contractor on this task order, which...
This is a delivery order under a multi-year, multi-award Indefinite Delivery Contract (IDC) awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the Broad Institute of MIT and Harvard. The $24,910,368.70 firm fixed-price task order is for the Broad Institute to provide genomics data generation, analysis, and management services in support of the NHLBI's Trans-Omics for Precision Medicine (TOPMed) initiative. This work will...
This is a $37,876,167 Firm Fixed Price definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI) to The Broad Institute, Inc., a non-profit research organization. The contract supports the Trans-Omics for Precision Medicine (TOPMed) initiative through genomics data generation, analysis, and management services. This is an indefinite delivery contract with a 10-year, $500 million ceiling. The Broad Institute was also awarded a multiple-award Indefinite Delivery Indefinite...
This is a $5,105,063.80 delivery order contract awarded to The Broad Institute, Inc., a non-profit biomedical and genomic research organization, by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute. The contract is part of the Centralized Omic REsource for TOPMed (CORE) master indefinite delivery, indefinite quantity (IDIQ) contract, which supports the Trans-Omics for Precision Medicine (TOPMed) program. The contract does not have a...
This federal contract award to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard, is valued at $1,285.00 and has no set-aside designation. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) for "OTHER FUNCTIONS SEQUENCING SERVICE." The Broad Institute is a non-profit biomedical and genomic research organization that partners with universities, medical centers, and companies to advance the understanding of human...
This $202,500 firm-fixed price purchase order was awarded to The Broad Institute, Inc. by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The contract is for whole genome sequencing of sickle cell patient blood samples, with a completion date of September 21, 2025. The Broad Institute is a non-profit biomedical and genomic research organization that frequently partners with government agencies like NIH, CDC, and DoD to provide...
This is a federal contract award valued at $394,227.01 to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard, a non-profit biomedical and genomic research organization. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), for TAS::75 0885::TAS BIOMEDICAL (APPLIED/EXPLORATORY) services. The contract has no set-aside designation. The Broad Institute frequently partners...

This federal contract award was issued by the National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard. The $2,343,147.64 firm fixed price contract is a delivery order under the Centralized Omic REsource for TOPMed (CORE) indefinite delivery vehicle (IDV), which has a $500 million ceiling to support the Trans-Omics for Precision Medicine initiative through genomics data generation, analysis, and management services. The Broad Institute, a non-profit biomedical and genomic research organization, will perform the work in Cambridge, MA. This contract has no set-aside designation, reflecting the Broad's status as a large non-profit research institution that frequently partners with academic and industry entities on federal contracts and grants to advance scientific research across a range of disease areas.

Generated 2/1/25, 10:21 AM